Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Gentium Shareholders Sue to Stop Jazz Pharmaceuticals Deal

Jan. 15 (Bloomberg) -- Gentium SpA’s board was sued by shareholders seeking to stop Jazz Pharmaceuticals Plc from buying the rare-disease drug developer because they claim the $1 billion deal is “hopelessly flawed.”

The plaintiffs also sued Jazz, alleging that the tender offer to acquire Gentium for $57 a share was designed to ensure the sale on terms that were “preferential” to Gentium’s board and Jazz.

Gentium’s board and the company will receive more than $360 million from the sale of their illiquid holdings, according to the proposed class action, or group lawsuit, filed today in Manhattan federal court. The defendants breached their fiduciary duty to secure the best price possible for Gentium’s shares and filed false and misleading documents with the U.S. Securities and Exchange Commission, according to the investors.

Jazz, which is based in Dublin, agreed last month to buy Villa Guardia, Italy-based Gentium in a tender offer that will expire on Jan. 22. Jazz is the maker of the narcolepsy treatment Xyrem, which was expected to generate sales of $567 million last year, according to the average of eight analysts’ estimates compiled by Bloomberg.

Laurie Hurley, a spokeswoman for Jazz, and Chelsea Wheeler, a spokeswoman for Gentium, didn’t immediately return a voice-mail message left at their offices after regular business hours seeking comment on the lawsuit.

Xavion Jyles v. Gentium, 14-CV-287, U.S. District Court, Southern District of New York (Manhattan).

To contact the reporter on this story: Patricia Hurtado in Federal Court in Manhattan at

pathurtado@bloomberg.net

To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.